glp-1 drugs side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists Ozempic and GLP-1 Drugs: Risk
Description
Older adults and postmenopausal women face a higher risk of bone loss
57 (2), R93r108
Available from: Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D et al (2024) Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
These synthetic analogs are also chemically modified to resist enzymatic degradation, allowing them to remain active in your bloodstream for hours to days rather than minutes
Paluch AE, Boyer WR, Franklin BA, Laddu D, Lobelo F, Lee DC, et al
